• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZIV6-35-125-6.0-120-PTX
Device Problem Occlusion Within Device (1423)
Patient Problems Thrombosis (2100); Surgical procedure, additional (2564)
Event Date 08/27/2014
Event Type  Injury  
Event Description
On the (b)(4) 2012 one zfv6-35-80-6-80 and three zilver ptx stents (ziv6-35-125-6.0--120-ptx lot# unk qty: 2 and ziv6-35-125-7.0-120-ptx lot# unk qty:1) were placed in a long cto lesion in left sfa.June 2014, the pt complained of pain.On the (b)(6) 2014 ultrasonography confirmed the occlusion due to thrombosis in entire lesion where the stents were placed (in all of the four stents).On the (b)(6) 2014 treatment with a laser, removal of the thromb and pta was performed against this thrombosis, through which the patency of the vessel improved to more than 50%.This report relates to 1 x ziv6-35-125-6.0-120-ptx device.Reference also related reports 3001845548-2014-00219 and 3001845648-2014-00221.
 
Manufacturer Narrative
The device involved in this complaint was not available for eval (the stent remains implanted in the pt).With the info provided, a document based investigation was carried out.Images were requested to support the complaint investigation, however to date no images were provided.From the complaint info and pt's pre-existing conditions, it is known that the pt had known potential risk factors for thrombosis such as long target lesion, lesion totally occluded prior to stent placement, advanced age (81), hypertension and previous smoker.Based on the above it may be noted that the pt had some risk factors that could have contributed to thrombosis event in this case.It is very unlikely that thrombosis could have occurred due to zilver ptx malfunction, however a definitive root cause of this stent thrombosis cannot be determined.The complaint is confirmed based on customer testimony.It may be noted that thrombosis is a known potential adverse effect as per the instructions for use.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.A review of the relevant mfg records could not be conducted as no lot number was provided.According to info provided treatment with a laser, removal of the thrombi and pta was performed against this thrombosis, through which the patency of the vessel improved to more than 50%.Quality engineering will continue to monitor complaints of this nature for potential emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
limerick
EI 
Manufacturer Contact
sinead quaid, sr specialist
EI  
61334440
MDR Report Key4249615
MDR Text Key5016448
Report Number3001845648-2014-00220
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100022/S001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/08/2014,10/06/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberZIV6-35-125-6.0-120-PTX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date08/27/2014
Event Location Hospital
Initial Date Manufacturer Received 10/09/2014
Initial Date FDA Received11/04/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age81 YR
-
-